InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
20
T+90 hit rate
33%
T+90 mean return
-29.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by ROBIN HOWARD W, Chairman & CEO. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. In total, 29 reports have been recorded. Split: 0 buy · 20 sells. Total volume traded: €1.2m. Activity tracked since 17 May 2021. The latest transaction was filed on 19 May 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations29 total
23,208 shares@ US$0.671.3% of flowCommon StockSEC:0000950170-25-075976:0
23,774 shares@ US$1.012.2% of flowCommon StockSEC:0000950170-25-025035:0
46,995 shares@ US$1.014.2% of flowCommon StockSEC:0000950170-24-138693:0
410,625 shares0Common StockSEC:0000950170-24-137543:0
16,278 shares@ US$1.011.5% of flowCommon StockSEC:0000950170-24-129461:0
14,881 shares@ US$1.281.6% of flowCommon StockSEC:0000950170-24-099352:0
16,650 shares@ US$1.752.5% of flowCommon StockSEC:0000950170-24-062646:0
20,033 shares@ US$0.681.2% of flowCommon StockSEC:0000950170-24-019043:0
19,877 shares@ US$0.490.8% of flowCommon StockSEC:0001209191-23-056182:0
19,998 shares@ US$0.781.4% of flowCommon StockSEC:0001209191-23-046460:0
20,361 shares@ US$0.721.3% of flowCommon StockSEC:0001209191-23-030446:0
19,635 shares@ US$3.005.2% of flowCommon StockSEC:0001209191-23-010952:0
38,014 shares@ US$3.5712.3% of flowCommon StockSEC:0001209191-22-057964:0
410,625 shares0Common StockSEC:0001209191-22-046486:0
68,450 shares0Common StockSEC:0001209191-22-029902:0
12,480 shares@ US$10.950.0050% mcap47.1% of flowCommon StockSEC:0001209191-22-011438
12,480 shares@ US$10.950.0050% mcap17.6% of flowCommon StockSEC:0001209191-22-011438:0
126,050 shares0Common StockSEC:0001209191-21-070692
126,050 shares0Common StockSEC:0001209191-21-070692:0
94,100 shares0Common StockSEC:0001209191-21-065222:0
94,100 shares0Common StockSEC:0001209191-21-065222
11,515 shares@ US$13.8312.7% of flowCommon StockSEC:0001209191-21-052391
11,515 shares@ US$13.830.0057% mcap19.7% of flowCommon StockSEC:0001209191-21-052391:0
11,560 shares@ US$18.300.0073% mcap25.4% of flowCommon StockSEC:0001209191-21-034187:0
11,560 shares@ US$18.30100.0% of flowCommon StockSEC:0001209191-21-034187
25 of 29 declarations
About ROBIN HOWARD W
ROBIN HOWARD W is the President & CEO at NEKTAR THERAPEUTICS. He is responsible for the strategic direction of the company and oversees all operations. His leadership and expertise in the biopharmaceutical sector are essential for the success of the organization.
